BRCA1 and BRCA2: 1994 and beyond

Narod, Steven A., Foulkes, William D.·2004·Nature Reviews Cancer

Cited by (978)

Items 101–200 of 978

  1. Negative Regulation of AKT Activation by BRCA1
    Xiang Tao, Amiko Ohashi, Yuping Huang, Tej K. Pandita, Thomas Ludwig, Simon N. Powell, Qin Yang · 2008 · Cancer Research
  2. The human Rothmund-Thomson syndrome gene product, RECQL4, localizes to distinct nuclear foci that coincide with proteins involved in the maintenance of genome stability
    Maja Petkovic, Tobias Dietschy, Raimundo Freire, Renjie Jiao, Igor Štagljar · 2005 · Journal of Cell Science
  3. A guide for functional analysis ofBRCA1variants of uncertain significance
    Gaël A. Millot, Marcelo Alex Carvalho, Sandrine M. Caputo, Maaike P.G. Vreeswijk, Melissa A. Brown, Michelle Webb, Étienne Rouleau, Susan L. Neuhausen, Thomas van Overeem Hansen, Alvaro Galli et al. · 2012 · Human Mutation
  4. Central body fatness is a stronger predictor of cancer risk than overall body size
    Amanda M. Barberio, Asalah Alareeki, Benjamin Viner, Joy Pader, Jennifer E. Vena, Paul Arora, Christine M. Friedenreich, Darren R. Brenner · 2019 · Nature Communications
  5. Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis
    Alexandra J. van den Broek, Marjanka K. Schmidt, Laura van ‘t Veer, Rob A.�E.�M. Tollenaar, Flora E. van Leeuwen · 2015 · PLoS ONE
  6. BRCA1 Promotes Unloading of the CMG Helicase from a Stalled DNA Replication Fork
    David T. Long, Vladimir Joukov, Magda Budzowska, Johannes C. Walter · 2014 · Molecular Cell
  7. Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia
    Lars Bullinger, Frank G. Rücker, Stephan Kurz, Juan Du, Claudia Scholl, Sandrine Sander, Andrea Corbacioglu, Claudio Lottaz, Jürgen Krauter, Stefan Fröhling et al. · 2007 · Blood
  8. BRCA1 Is Required for Postreplication Repair after UV-Induced DNA Damage
    Shailja Pathania, Jenna Nguyen, Sarah J. Hill, Ralph Scully, Guillaume Adelmant, Jarrod A. Marto, Jean Feunteun, David M. Livingston · 2011 · Molecular Cell
  9. BRD7, a Subunit of SWI/SNF Complexes, Binds Directly to BRCA1 and Regulates BRCA1-Dependent Transcription
    Mary T. Harte, Garrett J. O'Brien, Niamh Ryan, Julia J. Gorski, Kienan I. Savage, Nyree Crawford, Paul B. Mullan, Denis Paul Harkin · 2010 · Cancer Research
  10. Hereditary Breast Cancer: Clinical, Pathological and Molecular Characteristics
    Martin Jakob Larsen, Mads Thomassen, Anne‐Marie Gerdes, Torben Arvid Kruse · 2014 · Breast Cancer Basic and Clinical Research
  11. Centrosomal Microtubule Nucleation Activity Is Inhibited by BRCA1-Dependent Ubiquitination
    Satish Sankaran, Lea M. Starita, Aaron Chris Groen, Min Ji Ko, Jeffrey D. Parvin · 2005 · Molecular and Cellular Biology
  12. The Predominant Role of Surgery in the Prevention and New Trends in the Surgical Treatment of Women With BRCA1/2 Mutations
    Michael Fatouros, Georgios Baltoyiannis, Dimitrios H Roukos · 2007 · Annals of Surgical Oncology
  13. PARP Inhibitors: Clinical Limitations and Recent Attempts to Overcome Them
    Dongha Kim, Hye Jin Nam · 2022 · International Journal of Molecular Sciences
  14. Hereditary ovarian cancer
    Antonio Dello Russo, Valentina Calò, Loredana Bruno, Sérgio Rizzo, Viviana Bazan, Gaetana Di Fede · 2008 · Critical Reviews in Oncology/Hematology
  15. Skp2: A novel potential therapeutic target for prostate cancer
    Zhiwei Peter Wang, Daming Gao, Hidefumi Fukushima, Hiroyuki Inuzuka, Pengda Liu, Lixin Wan, Fazlul H. Sarkar, Wenyi Wei · 2011 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  16. Patterns of recurrence and metastasis in BRCA1/BRCA2‐associated breast cancers
    Yun Song, William Thomas Barry, Davinia S. E. Seah, Nadine Tung, Judy Ellen Garber, NU Lin · 2019 · Cancer
  17. Translational advances regarding hereditary breast cancer syndromes
    Michele Maiko Gage, Daniel J Wattendorf, Leonard R. Henry · 2012 · Journal of Surgical Oncology
  18. Histone Methyltransferase EZH2 Induces Akt-Dependent Genomic Instability and BRCA1 Inhibition in Breast Cancer
    Maria Elena Gonzalez, Matthew L. DuPrie, Heather Krueger, Sofia Diana Merajver, Alejandra C. Ventura, Kathy A. Toy, Celina Graciela Kleer · 2011 · Cancer Research
  19. Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population
    Cecelia A. Bellcross, Amy A. Lemke, Laura S. Pape, Angela Tess, Lorraine T. Meisner · 2009 · Genetics in Medicine
  20. Tumour suppressor genes in chemotherapeutic drug response
    Dulcie Lai, Stacy Grieve, Xiaolong Yang · 2012 · Bioscience Reports
  21. The role of BRCA1 in DNA double-strand repair: Past and present
    Caestecker, Kevin W., Van de Walle, Gerlinde R. · 2013 · Experimental Cell Research
  22. The SWI/SNF Chromatin Remodeling Subunit BAF57 Is a Critical Regulator of Estrogen Receptor Function in Breast Cancer Cells
    Juana Maria Garcia-Pedrero, Evangelos Kiskinis, Malcolm G. Parker, Borja Belandia · 2006 · Journal of Biological Chemistry
  23. Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours
    Darci T. Butcher, David I. Rodenhiser · 2006 · European Journal of Cancer
  24. Predicting drug response and toxicity based on gene polymorphisms
    Jacques Robert, Valérie Le Morvan, Denis Michel Smith, Philippe Pourquier, Jacques Bonnet · 2005 · Critical Reviews in Oncology/Hematology
  25. Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility
    Joanna R. Morris, Laurent Pangon, Chris Boutell, Toyomasa Katagiri, N.H. Keep, Ellen Solomon · 2006 · Human Molecular Genetics
  26. Prognostic Role of HuR in Hereditary Breast Cancer
    Mira Heinonen, Rainer Fagerholm, Kirsimari Aaltonen, Outi Kilpivaara, Kristiina Aittomäki, CARL P. BLOMQVIST, Päivi Heikkilä, Caj H. Haglund, Heli A. Nevanlinna, Ari P. Ristimaki · 2007 · Clinical Cancer Research
  27. In Brief: BRCA1 and BRCA2
    William David Foulkes, Andrew Y. Shuen · 2013 · The Journal of Pathology
  28. Population genetic testing for cancer susceptibility: founder mutations to genomes
    William David Foulkes, Bartha Maria Knoppers, Clare Turnbull · 2015 · Nature Reviews Clinical Oncology
  29. Aberrant alternative splicing in breast cancer
    Quan Yang, Jinyao Zhao, Wenjing Zhang, Dan Chen, Yang Wang · 2019 · Journal of Molecular Cell Biology
  30. Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor
    Yao Xiong, Yin Guo, Ye Liu, Hexiang Wang, Wenfeng Gong, Yong Liu, Xing Wang, Yajuan Gao, Fenglong Yu, Dan Su et al. · 2020 · Neoplasia
  31. Recent advances in understanding of the DNA double-strand break repair machinery of plants
    Jean‐Yves Bleuyard, Maria Eugenia Gallego, Charles I. White · 2005 · DNA repair
  32. Links between DNA double strand break repair and breast cancer: Accumulating evidence from both familial and nonfamilial cases
    Ranju Ralhan, Jasbir Kaur, R. Kreienberg, Lisa Wiesmüller · 2006 · Cancer Letters
  33. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome
    Dimitrios H Roukos, Evangelos C. Briasoulis · 2007 · Nature Clinical Practice Oncology
  34. Genomic rearrangements in BRCA1 and BRCA2: a literature review
    Ingrid Petroni Ewald, Patrícia Lisbôa Izetti Ribeiro, Edenir Inêz Palmero, Silvia Liliana Cossio, Roberto Giugliani, Patrícia Ashton‐Prolla · 2009 · Genetics and Molecular Biology
  35. Chemistry and Biology of Acylfulvenes: Sesquiterpene-Derived Antitumor Agents
    Marina Tanasova, Shana J. Sturla · 2012 · Chemical Reviews
  36. Assessing BRCA Carrier Probabilities in Extended Families
    Carlos Hernando Barcenas, GM Monawar Hosain, Banu K Arun, Jihong Zong, Xiaojun Zhou, Jianfang Chen, Jill M. Cortada, Gordon Brent Mills, Gail Elizabeth Tomlinson, Alexander R. Miller et al. · 2006 · Journal of Clinical Oncology
  37. Pancreatic Cancer Genetics
    Laufey Thora Amundadottir · 2016 · International Journal of Biological Sciences
  38. Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families: Table 1
    Amanda Woodward, T A Davis, A G S Silva, J A Kirk, J A Leary · 2005 · Journal of Medical Genetics
  39. Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer
    Zsofia Kinga Stadler, Erin E. Salo‐Mullen, Sujata M. Patil, Maria Catherine Pietanza, Joseph Vijai, Emmanouil S. Saloustros, Nichole A. L. Hansen, Noah D. Kauff, Robert C. Kurtz, David Paul Kelsen et al. · 2011 · Cancer
  40. DNA Repair Capacity of Lymphoblastoid Cell Lines From Sisters Discordant for Breast Cancer
    D. O. Kennedy, Meenakshi Agrawal, Jing Shen, Mary Beth Terry, F. F. Zhang, Ruby T. Senie, Grażyna Motykiewicz, Regina M. Santella · 2005 · JNCI Journal of the National Cancer Institute
  41. BRCA1 and BRCA2 mutations and the risk for colorectal cancer
    Victoria Sopik, Catherine Phelan, Cezary Cybulski, Steven Alexander Narod · 2014 · Clinical Genetics
  42. Total-Genome Analysis of BRCA1/2-Related Invasive Carcinomas of the Breast Identifies Tumor Stroma as Potential Landscaper for Neoplastic Initiation
    Frank Weber, Lei Shen, Koichi Fukino, Attila Patócs, George L. Mutter, Trinidad Caldés, Charis Eng · 2006 · The American Journal of Human Genetics
  43. Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers
    HEBON, Anouk Pijpe, Peggy Manders, Richard M. Brohet, Margriet J Collee, Senno Verhoef, Hans F. A. Vasen, Nicoline Hoogerbrugge, Christie J. van Asperen, Charlotte J. Dommering et al. · 2009 · Breast Cancer Research and Treatment
  44. Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers
    Chao-Guo Cao, Jie Yang, Yong Xia Chen, Peiting Zhou, Yingwei Wang, Wu Du, Lifeng Zhao, Yuanwei Chen · 2020 · Journal of Medicinal Chemistry
  45. Basal-like Breast Carcinoma: From Expression Profiling to Routine Practice
    Emad A. Rakha, Jorge Sergio Reis-Filho · 2009 · Archives of Pathology & Laboratory Medicine
  46. Exome-wide somatic mutation characterization of small bowel adenocarcinoma
    Ulrika A. Hänninen, Riku Katainen, Tomas J. Tanskanen, Roosa‐Maria Plaketti, Riku Laine, Jiri Hamberg, Ari P. Ristimaki, ­Eero Pukkala, Minna Taipale, Jukka‐Pekka Mecklin et al. · 2018 · PLoS Genetics
  47. Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study
    Annegien Broeks, Linde M. Braaf, Angelina Huseinovic, Anke Nooijen, Jos H. M. Urbanus, Frans B.L. Hogervorst, Marjanka K. Schmidt, Jan G.M. Klijn, Nicola S. Russell, Flora E. van Leeuwen et al. · 2007 · Breast Cancer Research
  48. Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil
    Magda Conceição Barbosa Gomes, Maurício Magalhães Costa, Radovan Borojević, Álvaro N.A. Monteiro, Roberto José da Silva Vieira, Sérgio Koifman, Rosalina Jorge Koifman, Song Li, Robert Royer, Shiyu Zhang et al. · 2006 · Breast Cancer Research and Treatment
  49. Cisplatin Resistance: Genetic and Epigenetic Factors Involved
    Yuliannis Lugones, Pía Loren, Luis Antonio Salazar · 2022 · Biomolecules
  50. Regulation of BRCA2 Gene Expression by the SLUG Repressor Protein in Human Breast Cells
    Manish K. Tripathi, Smita Misra, Sheetal V. Khedkar, Nalo M. Hamilton, Charletha V. Irvin-Wilson, Chakradhari Sharan, Linda J. Sealy, Gautam Chaudhuri · 2005 · Journal of Biological Chemistry
  51. Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks
    Dimitrios H Roukos · 2010 · The Pharmacogenomics Journal
  52. BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis
    Yaning Zhu, Jian Wu, Chengwan Zhang, Suan Sun, Jian Zhang, Wenjie Liu, Jian Huang, Zhihong Zhang · 2016 · Oncotarget
  53. S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy
    Jianjie Li, Xiaodong Shu, Jun Xu, Sek Man Su, Un In Chan, Lihua Mo, Jianlin Liu, Xin Zhang, Ragini Adhav, Qiang Chen et al. · 2022 · Nature Communications
  54. Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population
    Wijden Mahfoudh, Noureddine Bouaouina, Slim Ben Ahmed, Sallouha Gabbouj, Jingxuan Shan, Rebecca Mathew, Nancy A. Uhrhammer, Yves‐Jean Bignon, Wafa Troudi, Amel Ben Ammar Elgaaïed et al. · 2011 · Molecular Biology Reports
  55. Antiprotease therapy in cancer: hot or not?
    Tamara T. Lah, María Beatriz Durán Alonso, Cornelis J.F. Van Noorden · 2006 · Expert Opinion on Biological Therapy
  56. Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program
    Anna Maria Chiarelli, Kristina M. Blackmore, Derek Muradali, Susan J. Done, Vicky Majpruz, Ashini Weerasinghe, Lucia Mirea, Andrea F. Eisen, Linda Rabeneck, Ellen Warner · 2019 · JNCI Journal of the National Cancer Institute
  57. High frequency of BRCA1 5382insC mutation in Russian breast cancer patients
    Анна Петровна Соколенко, Natalia V. Mitiushkina, Konstantin G. Buslov, Елена Михайловна Бит-Сава, Aglaya G. Iyevleva, Елена Васильевна Преображенская, Ekatherina Sh. Kuligina, Yulia M. Ulibina, Maxim E. Rozanov, Evgeny N. Suspitsin et al. · 2006 · European Journal of Cancer
  58. The CHEK2 I157T Variant and Colorectal Cancer Susceptibility: A Systematic Review and Meta-analysis
    Chuan Liu, Qingshui Wang, Yajie Wang · 2012 · Asian Pacific Journal of Cancer Prevention
  59. RAP80 and RNF8, key players in the recruitment of repair proteins to DNA damage sites
    Jun Yan, Anton M. Jetten · 2008 · Cancer Letters
  60. Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations
    Sharon Maor, Ady Yosepovich, Moshe Zvi Papa, Ronit I. Yarden, Doris Mayer, Eitan Friedman, Haim Werner · 2007 · Cancer Letters
  61. Multifaceted role of EZH2 in breast and prostate tumorigenesis
    Gauri Deb, Vijay S. Thakur, Sanjay Gupta · 2013 · Epigenetics
  62. Misbehaviour of XIST RNA in Breast Cancer Cells
    Silvia Maria Sirchia, Silvia Maria Tabano, Laura Monti, Maria Paola Recalcati, Manuela Gariboldi, Francesca Romana Grati, Giovanni Porta, Palma Finelli, Paolo Radice, Monica Rosa Miozzo · 2009 · PLoS ONE
  63. DNA double-strand break signaling and human disorders
    Toshiyuki Bohgaki, Miyuki Bohgaki, Razqallah Hakem · 2010 · Genome Integrity
  64. BRCC36 Is Essential for Ionizing Radiation–Induced BRCA1 Phosphorylation and Nuclear Foci Formation
    Xiaowei Chen, Cletus A. Arciero, Chunrong Wang, Dominique Broccoli, Andrew K. Godwin · 2006 · Cancer Research
  65. The role of arginine methylation in the DNA damage response
    Yannick Auclair, Stéphane Richard · 2013 · DNA repair
  66. BRCA1 Induces Major Energetic Metabolism Reprogramming in Breast Cancer Cells
    Maud Privat, Nina Radosevic‐Robin, Corinne Aubel, Anne Cayre, Frederique Madeleine Penault-Llorca, Geoffroy Marceau, Vincent Sapin, Yves‐Jean Bignon, Daniel Morvan · 2014 · PLoS ONE
  67. Trypanosoma brucei BRCA2 acts in antigenic variation and has undergone a recent expansion in BRC repeat number that is important during homologous recombination
    Claire L. Hartley, Richard McCulloch · 2008 · Molecular Microbiology
  68. Genetic Research into Bipolar Disorder: The Need for a Research Framework that Integrates Sophisticated Molecular Biology and Clinically Informed Phenotype Characterization
    Thomas G. Schulze · 2010 · Psychiatric Clinics of North America
  69. Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy
    Tadeusz Majewski, Sangkyou Lee, Joon Jeong, Dong Sup Yoon, Andrzej Kram, Mi‐Sook Kim, Tomasz Tuziak, Jolanta E. Bondaruk, Soo‐Yong Lee, Weon Seo Park et al. · 2008 · Laboratory Investigation
  70. Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in Cutaneous Leiomyomas May Aid in Identification of Patients With HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome)
    Benjamin Buelow, Jarish N. Cohen, Zoltán Nagymányoki, Norma Frizzell, Nancy M. Joseph, Timothy H. McCalmont, Karuna Garg · 2016 · The American Journal of Surgical Pathology
  71. BRCA1 tumor suppressor network: focusing on its tail
    Wang, Bin · 2012 · Cell & Bioscience
  72. Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer
    Juan Zhang, Jie Sun, Jiuan Chen, Lu Yao, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin et al. · 2016 · Breast Cancer Research and Treatment
  73. BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia
    Alexandra Ortiz Rodríguez, Marcia Llacuachaqui, Gonzalo Guevara Pardo, Robert Royer, Garrett P. Larson, Jeffrey N. Weitzel, Steven Alexander Narod · 2011 · Gynecologic Oncology
  74. Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: A WECARE Study Report
    Jonine L. Bernstein, Duncan C. Thomas, Roy E. Shore, Mark E. Robson, John D. Boice, Marilyn A. Stovall, Michael Andersson, Leslie Bernstein, Kathleen E. Malone, Anne S. Reiner et al. · 2013 · European Journal of Cancer
  75. Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia
    Анна Петровна Соколенко, Maxim E. Rozanov, Natalia V. Mitiushkina, Natalia Sherina, Aglaya G. Iyevleva, Елена Васильевна Преображенская, Konstantin G. Buslov, Evgeny S. Shilov, Alexandr V. Togo, Елена Михайловна Бит-Сава et al. · 2007 · Familial Cancer
  76. Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy
    Jiahui Xu, Shilian Hu, Guodong Shen, Gan Shen · 2016 · Cancer Cell International
  77. Ductal Carcinoma In Situ in BRCA Mutation Carriers
    E. Shelley Hwang, Jane McLennan, Dan H. Moore, Beth B. Crawford, Laura J. Esserman, John L. Ziegler · 2007 · Journal of Clinical Oncology
  78. Centrosome amplification in tumorigenesis
    Simon J. Anderhub, Alwin Krämer, Bettina Maier · 2012 · Cancer Letters
  79. BRCA1 Is Required for Meiotic Spindle Assembly and Spindle Assembly Checkpoint Activation in Mouse Oocytes1
    Bo Xiong, Sen Li, Jun‐Shu Ai, Shen Yin, Ying‐Chun Ouyang, Shao‐Chen Sun, Da‐Yuan Chen, Qing‐Yuan Sun · 2008 · Biology of Reproduction
  80. A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas
    Talia R. Donenberg, John Lunn, DuVaughn Curling, Theodore Turnquest, Elisa Krill-Jackson, Robert Royer, Steven Alexander Narod, Judith E. Hurley · 2010 · Breast Cancer Research and Treatment
  81. NBA1/MERIT40 and BRE Interaction Is Required for the Integrity of Two Distinct Deubiquitinating Enzyme BRCC36-containing Complexes
    Xin Hu, Jin Ah Kim, Andy Castillo, Michael Huang, Jianxin Liu, Bin Wang · 2011 · Journal of Biological Chemistry
  82. Genomic medicine: genetic variation and its impact on the future of health care
    Huntington F. Willard, Misha H. Angrist, Geoffrey S. Ginsburg · 2005 · Philosophical Transactions of the Royal Society B Biological Sciences
  83. Inherited Mutations in Breast Cancer Genes—Risk and Response
    Andrew Y. Shuen, William D. Foulkes · 2011 · Journal of Mammary Gland Biology and Neoplasia
  84. KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer
    Alaa T. Alshareeda, Ola H. Negm, Andrew R. Green, Christopher C. Nolan, Patrick J. Tighe, Nada Albarakati, Rebeka Sultana, Srinivasan Madhusudan, Ian Ogilvie Ellis, Emad A. Rakha · 2015 · British Journal of Cancer
  85. N-Methyl-N-nitrosourea as a mammary carcinogenic agent
    Ana I. Faustino‐Rocha, Rita M. Ferreira, Paula A. Oliveira, Adelina Gama, Mário Ginja · 2015 · Tumor Biology
  86. Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing
    Qi Zhao, Ewen F. Kirkness, Otávia L. Caballero, Pedro A. F. Galante, Raphael B. Parmigiani, Lee Edsall, Samantha Kuan, Zhen Ye, Samuel Levy, Ana Tereza Ribeiro de Vasconcelos et al. · 2010 · Genome biology
  87. Mutation of Arabidopsis BARD1 Causes Meristem Defects by Failing to Confine WUSCHEL Expression to the Organizing Center
    Pei Han, Qing Li, Yuxian Zhu · 2008 · The Plant Cell
  88. BRCAness: a deeper insight into basal-like breast tumors
    Simona De Summa, R. Pinto, D. Sambiasi, Daniela Petriella, Vivian Paradiso, Angelo Paradiso, Stefania Tommasi · 2013 · Annals of Oncology
  89. BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation
    Kannan Vaidyanathan, Smita Lakhotia, Harsha Ravishankar, Umaira Tabassum, Geetashree Mukherjee, Kumaravel Somasundaram · 2009 · Journal of Biosciences
  90. Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers
    Tatsuya Toyama, Hiroko Yamashita, Naoto Kondo, Katsuhiro Okuda, Satoru Takahashi, Hidefumi Sasaki, Hiroshi Sugiura, Hirotaka Iwase, Yoshitaka Fujii · 2008 · BMC Cancer
  91. The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation
    Adriana Valentini, J. Lubiński, T. Byrski, P. Ghadirian, P. Møller, H. Lynch, P. Ainsworth, S. Neuhausen, J. Weitzel, C. Singer et al. · 2013 · Breast Cancer Research and Treatment
  92. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing
    Helena Jernström, Niklas Loman, Oskar T. Johannsson, Åke Borg, Hakan Lars Olsson · 2005 · European Journal of Cancer
  93. Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation-Negative Hereditary Breast Cancer Families
    Noah D. Kauff, Nandita Mitra, Mark E. Robson, Karen E. Hurley, Shaokun Chuai, Deborah J. Goldfrank, E. Wadsworth, Johanna Lee, Tessa Cigler, Patrick Ivan Borgen et al. · 2005 · JNCI Journal of the National Cancer Institute
  94. Skin cancer risk inBRCA1/2mutation carriers
    Priyanka V. Gumaste, Lauren A. Penn, Rachel M. Cymerman, Tomas Kirchhoff, David Polsky, Beth N. McLellan · 2014 · British Journal of Dermatology
  95. Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review
    Ansgar Gerhardus, Henriette Schleberger, Brigitte Schlegelberger, Dorothea Gadzicki · 2007 · European Journal of Human Genetics
  96. Management of BRCA1/2 associated breast cancer: A systematic qualitative review of the state of knowledge in 2006
    Fabienne Liebens, Birgit Carly, A. Pastijn, Serge Rozenberg · 2006 · European Journal of Cancer
  97. Treatment options for patients with triple-negative breast cancer
    Rafael Santana-Dávila, Edith A. Perez · 2010 · Journal of Hematology & Oncology
  98. Breast MRI as an Adjunct to Mammography for Breast Cancer Screening in High-Risk Patients: Retrospective Review
    Antony Raikhlin, Belinda N. Curpen, Ellen Warner, Carrie Betel, Barbara Ayn Wright, Roberta A. Jong · 2015 · American Journal of Roentgenology
  99. Performance of Screening Breast MRI across Women with Different Elevated Breast Cancer Risk Indications
    Dorothy A. Sippo, Kristine Specht Burk, Sarah Mercaldo, Geoffrey M. Rutledge, Christine E. Edmonds, Zoe Guan, Kevin S. Hughes, Constance Dobbins Lehman · 2019 · Radiology
  100. The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy
    Vasily Giannakeas, Steven Alexander Narod · 2017 · Breast Cancer Research and Treatment